Gitto Stefano, Schepis Filippo, Andreone Pietro, Villa Erica
Department of Medical and Surgical Sciences, University of Bologna and Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, 40138 Bologna, Italy.
Research Centre for the Study of Hepatitis, University of Bologna, 40138 Bologna, Italy.
Metabolites. 2018 Feb 24;8(1):17. doi: 10.3390/metabo8010017.
In recent years, metabolomics has attracted great scientific attention. The metabolomics methodology might permit a view into transitional phases between healthy liver and nonalcoholic steatohepatitis. Metabolomics can help to analyze the metabolic alterations that play a main role in the progression of nonalcoholic steatohepatitis. Lipid, glucose, amino acid, and bile acid metabolism should be widely studied to understand the complex pathogenesis of nonalcoholic steatohepatitis. The discovery of new biomarkers would be important for diagnosis and staging of liver disease as well as for the assessment of efficacy of new drugs. Here, we review the metabolomics data regarding nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. We analyzed the main studies regarding the application of metabolomics methodology in the complex context of nonalcoholic steatohepatitis, trying to create a bridge from the basic to the clinical aspects.
近年来,代谢组学已引起科学界的广泛关注。代谢组学方法可能有助于洞察健康肝脏与非酒精性脂肪性肝炎之间的过渡阶段。代谢组学有助于分析在非酒精性脂肪性肝炎进展中起主要作用的代谢改变。应广泛研究脂质、葡萄糖、氨基酸和胆汁酸代谢,以了解非酒精性脂肪性肝炎的复杂发病机制。发现新的生物标志物对于肝病的诊断和分期以及新药疗效评估都将具有重要意义。在此,我们综述了关于非酒精性脂肪性肝病和非酒精性脂肪性肝炎的代谢组学数据。我们分析了在非酒精性脂肪性肝炎复杂背景下应用代谢组学方法的主要研究,试图搭建起从基础到临床各方面的桥梁。